Security key
03168L105
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)
CUSIP: 03168L105
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Class A Common Stock, par value $0.01
- Shares outstanding
- 313,041,907
- Total 13F shares
- 125,924,024
- Share change
- -17,094,565
- Total reported value
- $997,296,789
- Put/Call ratio
- 39%
- Reported price per share
- $7.92
- Number of holders
- 194
- Value change
- -$136,424,861
- Number of buys
- 115
- Number of sells
- 62
Security identity
Holder snapshot
Report period
Q4 2024
Institutions
194
Top holders
10
AMRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Amneal Pharmaceuticals, Inc. SEC filings
Amneal Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03168L105
Recent filing periods:
Ownership snapshot
Top reported holders of AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
UBS Group AG
13D/G signal
—
Evidence rows
15
Latest as of
30 Sep 2024
13F
3/4/5
Lead comparable stake: 7%
Showing 1-6 of 15 holder rows.
Rank 1 holder
UBS Group AG
13F
- Ownership
- 7%
- Position
- $181.15M
Rank 2 holder
VANGUARD GROUP INC
13F
- Ownership
- 4.7%
- Position
- $121.67M
Rank 3 holder
BlackRock, Inc.
13F
- Ownership
- 4%
- Position
- $103.26M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| UBS Group AG |
13F
Company
|
7%
|
$181,151,768
21,773,049 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
4.7%
|
$121,671,214
14,623,944 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
4%
|
$103,255,793
12,410,552 shares
|
— | 30 Sep 2024 |
| TPG GP A, LLC |
13F
3/4/5
Company · Former 10% Owner
|
3.9%
|
$102,575,341
12,328,767 shares
|
— | 30 Sep 2024 |
| Rubric Capital Management LP |
13F
Company
|
3.4%
|
$89,205,193
10,721,778 shares
|
— | 30 Sep 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
2.8%
|
$73,983,878
8,892,293 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
194
Shares
125,924,024
Rows available
194
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
180
Q4 2024 holders
194
Holder diff
14
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend